Contents
Academy · Research Writing · Type I vs Type II error
Type I and Type II Errors: Definitions, Trade-offs and Consequences in Study Design
False-positive and false-negative errors are not interchangeable; they have different causes and different consequences, and design choices that reduce one tend to increase the other.
A Type I error is the rejection of a true null hypothesis, that is, concluding that an effect exists when it does not. A Type II error is the failure to reject a false null hypothesis, that is, concluding that no effect exists when one does. The two are controlled by different parameters (alpha and beta) and trade off against each other in study design.
Learning objectives
- How alpha (the Type I error rate) and beta (the Type II error rate) are set, and what each controls.
- Why reducing alpha to limit false positives tends to increase the risk of a false negative.
- Why the consequences of the two errors differ according to the research question.
Common misconceptions
- “A smaller p-value threshold makes a study more rigorous overall.” Lowering alpha (e.g. from 0.05 to 0.01) reduces the Type I error rate, but at a fixed sample size it increases beta, the Type II error rate, making a true effect more likely to be missed; rigour requires both to be balanced rather than one to be minimised in isolation.
- “Type I and Type II errors are equally serious in every context.” The relative importance of each error is a judgement about the consequences of a wrong conclusion for the specific research question; a definitive confirmatory trial of a new drug, for example, is usually designed to hold alpha strictly at a low level. The missed cases and false positives of a diagnostic or screening test are a separate matter, described by the sensitivity and specificity of the test against a reference standard rather than by alpha and beta.
Definition and control of the two error types
Banerjee and colleagues set out the standard framework: a Type I error occurs when a true null hypothesis is incorrectly rejected, with its probability denoted alpha and conventionally set at 0.05; a Type II error occurs when a false null hypothesis is incorrectly not rejected, with its probability denoted beta1. Alpha is a design choice made before the study is conducted: it is the significance threshold against which the analysis will be judged. Beta is a consequence of the study design, principally its sample size and the magnitude of the effect sought: for a given effect size, a larger sample lowers beta.
The trade-off between alpha and beta
For a fixed sample size, a stricter significance threshold (a lower alpha) makes it more difficult to declare any result significant, and therefore also more difficult to detect a real effect, which raises beta. The only means of lowering both simultaneously is to increase the sample size, which is why sample-size calculations require the researcher to state a target alpha and a target power (1 minus beta) together, rather than alpha alone1. A study that reports only its alpha, without a stated power, has not specified the degree of protection it provides against a false negative.
Context-dependent consequences of each error type
The two errors are not symmetrical in their consequences, and the error that a study is designed to minimise should be determined by the cost of a wrong conclusion. A Type I error is rejection of a true null hypothesis; a Type II error is failure to reject a false null hypothesis. Statistical power equals 1 − β. In a confirmatory Phase III trial determining whether a new drug should be approved for widespread use, a Type I error (approving an ineffective or harmful drug) is usually judged the more costly error, which is why regulatory trials hold alpha strictly at a pre-specified low level. The accuracy of a diagnostic or screening test is a different question and is described separately: sensitivity is the proportion of people who have the condition according to the reference standard whom the test correctly classifies as positive, and specificity is the proportion of people without the condition according to the reference standard whom the test correctly classifies as negative.
Key points
Key points
A Type I error is a false positive and a Type II error is a false negative, and the two trade off against each other at a fixed sample size. A study design should state both its alpha and its power, and which error is of greater concern, rather than reporting only a significance threshold.
Practical application
Practical application
- Both alpha and target power should be stated before data collection. The significance threshold and the power that the sample size was calculated to achieve should both be specified, not alpha alone.
- The relative cost of each error for the specific research question should be determined, and the design should reflect it. Whether a false-positive or a false-negative conclusion would be the costlier error depends on the research question; a confirmatory trial usually prioritises control of the Type I error. The applicable situation and its rationale should be stated, and the sensitivity and specificity of any diagnostic or screening test should be reported separately from the trial’s alpha and power.
- A non-significant result from an underpowered study should be reported as inconclusive rather than as evidence of no effect. Failure to reject the null hypothesis with low power is consistent with either a true null hypothesis or a missed true effect, and the result does not distinguish between them.
Frequently asked questions
No. Alpha is the long-run rate of Type I errors across repeated studies under a true null hypothesis, not the probability that any single significant result is a false positive; the latter quantity also depends on the prior probability that the effect is real.
No. For any finite sample size there is an unavoidable trade-off; only an infinitely large sample could, in principle, reduce both toward zero simultaneously.
They are complements: power equals 1 minus beta. A study with 80% power has a beta (Type II error rate) of 20%.
References
- Banerjee A, Chitnis UB, Jadhav SL, Bhawalkar JS, Chaudhury S. Hypothesis testing, type I and type II errors. Industrial Psychiatry Journal. 2009;18(2):127-131. read 10 October 2026. View on PubMed Central
Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.
How to cite this article
Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.
Pubrica Academy. (2026, October 10). Type I and Type II Errors: Definitions, Trade-offs and Consequences in Study Design. Pubrica. https://pubrica.com/academy/concepts-definitions/type-i-vs-type-ii-error/
Pubrica Academy. “Type I and Type II Errors: Definitions, Trade-offs and Consequences in Study Design.” Pubrica, 10 Oct. 2026, pubrica.com/academy/concepts-definitions/type-i-vs-type-ii-error/.
Pubrica Academy (2026) Type I and Type II Errors: Definitions, Trade-offs and Consequences in Study Design. Pubrica. Available at: https://pubrica.com/academy/concepts-definitions/type-i-vs-type-ii-error/ (Accessed: 15 October 2026).
Pubrica Academy. “Type I and Type II Errors: Definitions, Trade-offs and Consequences in Study Design.” Pubrica. October 10, 2026. https://pubrica.com/academy/concepts-definitions/type-i-vs-type-ii-error/
Pubrica Academy, ‘Type I and Type II Errors: Definitions, Trade-offs and Consequences in Study Design’ (Pubrica, 10 October 2026) <https://pubrica.com/academy/concepts-definitions/type-i-vs-type-ii-error/> accessed 15 October 2026.
Pubrica Academy. Type I and Type II Errors: Definitions, Trade-offs and Consequences in Study Design. [Internet]. Pubrica; 2026 Oct 10 [cited 2026 Oct 15]. Available from: https://pubrica.com/academy/concepts-definitions/type-i-vs-type-ii-error/
Pubrica Academy, “Type I and Type II Errors: Definitions, Trade-offs and Consequences in Study Design,” Pubrica, Oct. 10, 2026. [Online]. Available: https://pubrica.com/academy/concepts-definitions/type-i-vs-type-ii-error/
@misc{type_i_vs_type_ii_error_2026,
author = {{Pubrica Academy}},
title = {Type I and Type II Errors: Definitions, Trade-offs and Consequences in Study Design},
howpublished = {Pubrica},
year = {2026},
month = {oct},
url = {https://pubrica.com/academy/concepts-definitions/type-i-vs-type-ii-error/},
note = {Accessed: <span data-cite-acc="iso">2026-10-15</span>}
}This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.
Alpha/beta design check
This checklist applies when the statistical-methods section is written.
[ ] Alpha (significance threshold) stated explicitly [ ] Target power (1 minus beta) stated explicitly [ ] Sample size justified against both, not alpha alone [ ] Stated which error (false positive or false negative) the design prioritises minimising, and why [ ] Non-significant results discussed as inconclusive where power was limited, not as proof of no effect
Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.
How Pubrica can help
Pubrica’s biostatisticians prepare sample-size and power calculations that state both alpha and beta explicitly, and assist in justifying the error against which the design is intended to protect.